Routine use of platelet components prepared with photochemical treatment (INTERCEPT platelets (TM)): Impact on clinical outcomes and resources.

Osselaer, Jean-Claude; Doyen, Chantal; Messe, N.; van Hooydonk, M.; Jacquet, M.; Sonet, Anne; Bosly, André; Flament, J.; Corash, L.

Routine use of platelet components prepared with photochemical treatment (INTERCEPT platelets (TM)): Impact on clinical outcomes and resources.

Osselaer, Jean-Claude

;

Doyen, Chantal

;

Messe, N.

;

van Hooydonk, M.

;

Corash, L.

;et.al.

(2005) 47th Annual Meeting of the American-Society-of-Hematology — Location: Atlanta(Ga) (10.December.2005)

Files

No attached file found for this publication.

Details

Authors

Osselaer, Jean-ClaudeUCLouvain
Author
Doyen, ChantalUCLouvain
Author
Messe, N.
Author
van Hooydonk, M.
Author
Bosly, AndréUCLouvain
Author
Corash, L.
Author

Affiliations

UCLouvainMD/MINT - Département de médecine interne

Citations

APA
Chicago
FWB

Osselaer, J.-C., Doyen, C., Messe, N., van Hooydonk, M., Jacquet, M., Sonet, A., Bosly, A., Flament, J., & Corash, L. (2005). Routine use of platelet components prepared with photochemical treatment (INTERCEPT platelets (TM)): Impact on clinical outcomes and resources. Blood, 106(11), 129A-129A. https://hdl.handle.net/2078.5/74426 (Original work published 2005)